Skip to content
10-K/A

Annual Report

ANTARES PHARMA, INC.

0001140361-22-017040

← back to feed
Filed
Apr 29, 2022 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2021 · Mar 31, 2022 170.58M sh